Physician profile
Matthew Staum
NPI 1598052342
$2,564.53
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.55 · 2020: $11.66 · 2021: $37.77 · 2022: $33.07 · 2023: $14.48 · 2024: $2,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,438 · Food and Beverage: $14.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,438.00 |
| Food and Beverage | $14.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,438.00 | 2024 | (7416) Lumify |
| Csl Behring | $31.81 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $24.48 | 2021 | |
| Abbvie INC. | $17.17 | 2022 | |
| Pfizer INC. | $15.90 | 2022 | |
| Mindray Ds USA, INC. | $14.48 | 2023 | Te X, Te7 Max |
| Astrazeneca Pharmaceuticals LP | $11.66 | 2020 | |
| Chiesi USA, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Staum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.